Mark Wilson Posted April 11, 2016 Report Share Posted April 11, 2016 Based upon the positive advisory committee meeting, it looks like Intercept Pharmaceuticals is going to get their treatment approved. Does anyone want to take a guess at what the stock will do between now and the FDA meeting on May 29th? Link to comment Share on other sites More sharing options...
Biotech Forecast Posted April 11, 2016 Report Share Posted April 11, 2016 The PDUFA date of May 29th, 2016 has been added to the event tracker. As a reminder, the company will have to do a confirmatory phase 4 trial per the requirements of the FDA accelerated approval. Link to comment Share on other sites More sharing options...
BioTrader Posted April 12, 2016 Report Share Posted April 12, 2016 This stock along with many other biotechnology stocks are in a down trend because of the political environment. With that being said FDA seems almost certain. I bet there will be more chatter about this upcoming approval than most and this will cause the stock increase in value despite and all the negative press about drug prices. Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.